On the recordMarch 21, 2023
By simply telling a generic drug manufacturer what adjustments they need to make, our bipartisan bill would help improve the generic market approval process and lower drug prices overall.
Source
congress.govEditor's note · Context
Discusses a bill aimed at improving generic drug approval and reducing prices.
Share & report
More from Maggie Hassan
Sep 24, 2024
Simply put, if you want to contract with the U.S. Government... then at a bare minimum you need to comply with U.S. law.
Sep 23, 2024
I am concerned about the possibility that if the legislation were written in such a way, or if contracting guidelines were scoped in such a way that companies could find loopholes, then that would be disastrous for us.
Jan 21, 2025
Mr. President, I rise to join my colleagues in opposing this legislation that is the Republican Party's latest effort to take away a woman's fundamental freedom to make her own healthcare decisions and take away a family's fundamental…
Dec 20, 2024
Mr. President, I will just say that I regret the objection. A Senate version of the reauthorization was, of course, included in the package that we all agreed on--bipartisan agreement in both the Senate and the House, after months and…
Other voices in this conversation
